New research suggests that individuals who stop using blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds far faster than those who stop conventional diet and exercise regimens.
Findings released in a major health publication demonstrates that while overweight individuals often shed substantial amounts of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing such treatments must be cognizant of the potential of fast weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment mass in about a year and a half.
Comparing Therapies
The study, which examined 37 of trials involving over 9,000 of patients, compared the effects of these new drugs with older methods.
Scientists note that people who lose weight through lifestyle changes alone usually see a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
The Reason for the Fast Regain
Doctors propose the mode of action of the injections accounts for the amplified regain.
The injections copy a natural hormone called GLP-1, which controls appetite.
"Sustained high doses of the hormone concentrations far above than normal may cause the body to produce less of its own natural GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making overeating a significant risk."
A Chronic Disease?
Health authorities suggest the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians say that, given the significant potential of relapse, the treatment should be considered ongoing.
This perspective is supported by drug manufacturers, who note that the findings "emphasize the persistent character of obesity," comparing it to managing diseases like diabetes.
User Accounts
Individuals who have come off the medication describe a intense resurgence of appetite.
"It felt as if a switch flipping and you become ravenous," described one woman.
The struggle is compounded if individuals have not developed sustainable lifestyle or habit modifications during therapy.
Growing Adoption
Survey data suggest that a significant number of adults in the UK have used these injections in the past year, with desire remaining high.
- Adoption is more common among females compared to males.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while these medications are powerful agents for weight loss, they are not a permanent fix and lasting health benefits hinges on ongoing behavioural management.
